Barely Significant
← all excerpts

CDKN2A loss-of-function predicts immunotherapy resistance in non-small cell lung cancer.

Sci Rep · 2021 · PMC8501138 · PMID 34625620

Europe PMCDOI
1
hedged sentence
0.0690
closest p · 1.4× alpha
0.0690
boldest claim

The sentences

borderline significantp = 0.069so close (0.05 < p ≤ 0.1)
Though the latter was only borderline significant on log-rank testing for PFS ( p = 0.069), this was likely due to the small sample size of the MSKCC validation cohort (N = 83) and the presence of confounding variables (PD-L1, TMB).

also in 11,409 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.